Interpace is a leader in enabling personalized medicine, offering advanced diagnostics, and providing molecular markers, data solutions and biopharma services. Our new business model leverages disease-specific, unique data and specialized service offerings along the therapeutic value chains from early diagnosis and prognostic planning to targeted therapeutic applications.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Clinical Utility Studies for Barregen
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):